Literature DB >> 20502502

Recombinant adenovirus-mediated expression of GHS-R1a in HEK 293 cells.

Li Liu1, Hua-Min Xu, Hong Jiang, Jun Wang, Ning Song, Jun-Xia Xie.   

Abstract

OBJECTIVE: To construct the recombinant adenovirus vector carrying human growth hormone secretagogue receptor type 1a (GHS-R1a), for genetic transfection.
METHODS: The full-length human GHS-R1a gene was obtained by PCR amplification and then cloned into the shuttle plasmid pAdTrack-CMV. The linearized plasmid pAdTrack-CMV-GHS-R1a was co-transformed into Escherichia coli (E. coli) BJ5183 cells along with an adenoviral backbone plasmid pAdEasy1. The HEK293 cells were then infected with adenoviruses. The expression of GHS-R1a was indicated by green fluorescent protein (GFP), and confirmed by Reverse Transcription Polymerase Chain Reaction (RT-PCR) and Western blot.
RESULTS: Enzymatic digestion of pAdGHS-R1a yielded a large fragment (approximately 30 kb) and a small fragment (4.5 kb), indicating the successful construction of recombinant adenovirus expression vector. Expression of GFP was observed by confocal laser scanning microscopy at 24 h after infection. RT-PCR and Western blot further confirmed that GHS-R1a was efficiently expressed in 293 cells.
CONCLUSION: Recombinant adenovirus (AdGHS-R1a) is successfully constructed, and the target gene can be expressed efficiently in 293 cells, which provide a valuable tool for further studying the function of GHS-R1a.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20502502      PMCID: PMC5560300          DOI: 10.1007/s12264-010-1228-1

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  24 in total

Review 1.  Adenovirus vectors as recombinant viral vaccines.

Authors:  J L Imler
Journal:  Vaccine       Date:  1995-09       Impact factor: 3.641

Review 2.  In vivo adenovirus-mediated gene transfer for Parkinson's disease.

Authors:  P Horellou; A Bilang-Bleuel; J Mallet
Journal:  Neurobiol Dis       Date:  1997       Impact factor: 5.996

Review 3.  Ghrelin: structure and function.

Authors:  Masayasu Kojima; Kenji Kangawa
Journal:  Physiol Rev       Date:  2005-04       Impact factor: 37.312

4.  Ghrelin stimulates proliferation and differentiation and inhibits apoptosis in osteoblastic MC3T3-E1 cells.

Authors:  Sang Wan Kim; Sun Ju Her; Seong Jae Park; Dohee Kim; Kyong Soo Park; Hong Kyu Lee; Byung Hee Han; Min Seon Kim; Chan Soo Shin; Seong Yeon Kim
Journal:  Bone       Date:  2005-09       Impact factor: 4.398

5.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

Review 6.  The ups and downs of adenovirus vectors.

Authors:  H S Ginsberg
Journal:  Bull N Y Acad Med       Date:  1996

7.  Ghrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigra.

Authors:  Hong Jiang; Lin-Jing Li; Jun Wang; Jun-Xia Xie
Journal:  Exp Neurol       Date:  2008-05-20       Impact factor: 5.330

8.  Overexpression of lentivirus-mediated glial cell line-derived neurotrophic factor in bone marrow stromal cells and its neuroprotection for the PC12 cells damaged by lactacystin.

Authors:  Ya-Ru Su; Jian Wang; Jian-Jun Wu; Yan Chen; Yu-Ping Jiang
Journal:  Neurosci Bull       Date:  2007-03       Impact factor: 5.203

9.  The mitogenic and antiapoptotic actions of ghrelin in 3T3-L1 adipocytes.

Authors:  Min Seon Kim; Cho Ya Yoon; Pil Geum Jang; Young Joo Park; Chan Soo Shin; Hye Sun Park; Je Won Ryu; Youngmi Kim Pak; Joong Yeol Park; Ki Up Lee; Seong Yeon Kim; Hong Kyu Lee; Young Bum Kim; Kyong Soo Park
Journal:  Mol Endocrinol       Date:  2004-06-03

Review 10.  Virus-mediated gene transfer to induce therapeutic angiogenesis: where do we stand?

Authors:  Mauro Giacca
Journal:  Int J Nanomedicine       Date:  2007
View more
  1 in total

1.  Chronic alcohol exposure exacerbates inflammation and triggers pancreatic acinar-to-ductal metaplasia through PI3K/Akt/IKK.

Authors:  Xin Huang; Xuqi Li; Qingyong Ma; Qinhong Xu; Wanxing Duan; Jianjun Lei; Lun Zhang; Zheng Wu
Journal:  Int J Mol Med       Date:  2014-12-29       Impact factor: 4.101

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.